SCHEMBL18688311

SCHEMBL18688311

CC1CCCC2(C)C3CCC4CCCC4(C)C3=CCC12

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 8/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18687835 0.82 ALDH1A1 (0.43) CYP19A1
SCHEMBL18688341 0.81 CYP19A1 (0.39) CYP19A1
SCHEMBL19967327 0.69 CDC25A (0.33) CYP19A1
SCHEMBL18688155 0.67 CDC25A (0.35) —
SCHEMBL18688659 0.66 CDC25A (0.39) CYP19A1
SCHEMBL6596976 0.65 ALOX15 (0.57) —
SCHEMBL14610507 0.63 CYP19A1 (0.39) CYP19A1
SCHEMBL20125707 0.62 RXRA (0.42) —
SCHEMBL9946957 0.62 ALOX15 (0.48) —
SCHEMBL10224357 0.62 NR1H3 (0.38) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018047176-A1 COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM AND USES THEREOF FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2018-03-15 — — WO disclosed
WO-2017051422-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2017-03-30 — — WO disclosed
WO-2017051423-A1 COMPOSITIONS COMPRISING TRITERPENOIDS REGENERA PHARMA LTD. (IL) 2017-03-30 — — WO disclosed
Send feedback